Table 2. Change of hematological parameters.
| Hematological parameters | SPB-201 | Placebo | p value | |||
|---|---|---|---|---|---|---|
| No. | Mean ± SD | No. | Mean ± SD | |||
| WBC (103/µL) | ||||||
| Baseline | 48 | 6.05 ± 1.51 | 48 | 6.28 ± 1.58 | 0.4704† | |
| Week 8 | 43 | 6.08 ± 1.13 | 44 | 6.49 ± 1.62 | ||
| Change from baseline | 43 | 0.08 ± 1.48 | 44 | 0.22 ± 1.11 | 0.5637† | |
| RBC (106/µL) | ||||||
| Baseline | 48 | 4.96 ± 0.46 | 48 | 4.88 ± 0.40 | 0.3460* | |
| Week 8 | 43 | 4.84 ± 0.49 | 44 | 4.81 ± 0.40 | ||
| Change from baseline | 43 | −0.12 ± 0.24 | 44 | −0.06 ± 0.21 | 0.1729† | |
| Hb (g/dL) | ||||||
| Baseline | 48 | 15.18 ± 1.35 | 48 | 15.06 ± 1.15 | 0.8173† | |
| Week 8 | 43 | 14.77 ± 1.45 | 44 | 14.86 ± 1.13 | ||
| Change from baseline | 43 | −0.41 ± 0.70 | 44 | −0.15 ± 0.61 | 0.0687* | |
| Hct (%) | ||||||
| Baseline | 48 | 44.86 ± 3.89 | 48 | 44.26 ± 3.13 | 0.4180† | |
| Week 8 | 43 | 43.62 ± 4.24 | 44 | 43.69 ± 3.34 | ||
| Change from baseline | 43 | −1.33 ± 2.11 | 44 | −0.47 ± 1.85 | 0.0462* | |
| MCV (FL) | ||||||
| Baseline | 48 | 90.55 ± 4.03 | 48 | 90.91 ± 4.58 | 0.6799* | |
| Week 8 | 43 | 90.34 ± 4.28 | 44 | 90.93 ± 4.20 | ||
| Change from baseline | 43 | −0.52 ± 1.99 | 44 | 0.02 ± 1.98 | 0.3287† | |
| Platelet (103/µL) | ||||||
| Baseline | 48 | 254.50 ± 54.01 | 48 | 266.90 ± 56.01 | 0.2725* | |
| Week 8 | 43 | 238.35 ± 46.65 | 44 | 268.73 ± 57.46 | ||
| Change from baseline | 43 | −16.88 ± 29.75 | 44 | 1.45 ± 27.54 | 0.0037* | |
| Segmented neutrophil (%) | ||||||
| Baseline | 48 | 53.39 ± 8.73 | 48 | 52.16 ± 8.30 | 0.4800* | |
| Week 8 | 43 | 53.09 ± 8.74 | 44 | 52.31 ± 8.42 | ||
| Change from baseline | 43 | −0.37 ± 7.26 | 44 | 0.87 ± 6.45 | 0.4018* | |
| Lymphocyte (%) | ||||||
| Baseline | 48 | 35.78 ± 7.89 | 48 | 37.94 ± 7.90 | 0.1828* | |
| Week 8 | 43 | 36.38 ± 8.48 | 44 | 37.67 ± 7.60 | ||
| Change from baseline | 43 | 0.71 ± 7.34 | 44 | −0.85 ± 5.62 | 0.2683* | |
| Monocyte (%) | ||||||
| Baseline | 48 | 6.96 ± 1.44 | 48 | 6.61 ± 1.60 | 0.2236† | |
| Week 8 | 43 | 6.97 ± 1.91 | 44 | 6.44 ± 1.52 | ||
| Change from baseline | 43 | 0.04 ± 1.36 | 44 | −0.23 ± 1.12 | 0.3250* | |
| Eosinophil (%) | ||||||
| Baseline | 48 | 3.23 ± 2.80 | 48 | 2.68 ± 1.66 | 0.4635† | |
| Week 8 | 43 | 3.36 ± 3.64 | 44 | 2.90 ± 2.09 | ||
| Change from baseline | 43 | 0.04 ± 1.48 | 44 | 0.14 ± 1.53 | 0.9425† | |
| Basophil (%) | ||||||
| Baseline | 48 | 0.68 ± 0.29 | 48 | 0.63 ± 0.22 | 0.3472* | |
| Week 8 | 43 | 0.71 ± 0.39 | 44 | 0.69 ± 0.29 | ||
| Change from baseline | 43 | 0.04 ± 0.29 | 44 | 0.05 ± 0.24 | 0.5714† | |
WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume
Compared between groups: *p value by 2 sample t-test; †p value by Wilcoxon rank sum test.